Free Trial
NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

RadNet logo
$55.46 -1.13 (-2.00%)
Closing price 04:00 PM Eastern
Extended Trading
$57.02 +1.56 (+2.81%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About RadNet Stock (NASDAQ:RDNT)

Key Stats

Today's Range
$55.43
$59.28
50-Day Range
$54.87
$61.14
52-Week Range
$45.00
$93.65
Volume
758,831 shs
Average Volume
684,741 shs
Market Capitalization
$4.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.60
Consensus Rating
Strong Buy

Company Overview

RadNet Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

RDNT MarketRank™: 

RadNet scored higher than 80% of companies evaluated by MarketBeat, and ranked 327th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    RadNet has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    RadNet has only been the subject of 1 research reports in the past 90 days.

  • Read more about RadNet's stock forecast and price target.
  • Earnings Growth

    Earnings for RadNet are expected to decrease by -5.36% in the coming year, from $0.56 to $0.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of RadNet is 269.48, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of RadNet is 269.48, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.56.

  • Price to Book Value per Share Ratio

    RadNet has a P/B Ratio of 3.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about RadNet's valuation and earnings.
  • Percentage of Shares Shorted

    9.33% of the float of RadNet has been sold short.
  • Short Interest Ratio / Days to Cover

    RadNet has a short interest ratio ("days to cover") of 9.4.
  • Change versus previous month

    Short interest in RadNet has recently decreased by 0.15%, indicating that investor sentiment is improving.
  • Dividend Yield

    RadNet does not currently pay a dividend.

  • Dividend Growth

    RadNet does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.33% of the float of RadNet has been sold short.
  • Short Interest Ratio / Days to Cover

    RadNet has a short interest ratio ("days to cover") of 9.4.
  • Change versus previous month

    Short interest in RadNet has recently decreased by 0.15%, indicating that investor sentiment is improving.
  • News Sentiment

    RadNet has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for RadNet this week, compared to 7 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,613,220.00 in company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of RadNet is held by insiders.

  • Percentage Held by Institutions

    77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about RadNet's insider trading history.
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Stock News Headlines

Critical Review: RadNet (NASDAQ:RDNT) and Ceres Ventures (OTCMKTS:CEVE)
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

RDNT Stock Analysis - Frequently Asked Questions

RadNet's stock was trading at $69.84 at the beginning of 2025. Since then, RDNT shares have decreased by 20.6% and is now trading at $55.46.

RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Thursday, February, 27th. The medical research company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.01. The medical research company earned $477.10 million during the quarter, compared to analyst estimates of $459.42 million. RadNet had a positive trailing twelve-month return on equity of 1.41% and a negative net margin of 1.73%.
Read the conference call transcript
.

RadNet's top institutional investors include Harbor Capital Advisors Inc. (0.57%), E. Ohman J or Asset Management AB (0.04%), Wealth Enhancement Advisory Services LLC (0.02%) and Steigerwald Gordon & Koch Inc. (0.01%). Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, Ranjan Jayanathan, David L Swartz, Lawrence L Levitt, Mark Stolper, David Jeffrey Katz, Cornelis Wesdorp, Michael N Murdock, Christine Nayoma Gordon and Gregory E Spurlock.
View institutional ownership trends
.

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Broadcom (AVGO) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
2/27/2025
Today
7/15/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:RDNT
CIK
790526
Employees
11,021
Year Founded
1980

Price Target and Rating

High Price Target
$80.00
Low Price Target
$60.00
Potential Upside/Downside
+25.5%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
99.04
P/E Growth
N/A
Net Income
$2.79 million
Net Margins
-1.73%
Pretax Margin
0.44%
Return on Equity
1.41%
Return on Assets
0.48%

Debt

Debt-to-Equity Ratio
0.87
Current Ratio
2.01
Quick Ratio
2.01

Sales & Book Value

Annual Sales
$1.87 billion
Price / Sales
2.23
Cash Flow
$3.48 per share
Price / Cash Flow
15.93
Book Value
$15.31 per share
Price / Book
3.62

Miscellaneous

Outstanding Shares
75,030,000
Free Float
70,828,000
Market Cap
$4.16 billion
Optionable
Optionable
Beta
1.41

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:RDNT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners